Gene Expression Profiling in Glomeruli from Human Kidneys with Diabetic Nephropathy

American Journal of Kidney Diseases

Volumn 43, Issue 4, 2004, Pages 636-650

  Baelde, Hans J ^a   Eikmans, Michael ^b   Doran, Peter P ^b   Lappin, David W P ^b   De Heer, Emile ^b   Bruijn, Jan A ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

Diabetic nephropathy (DN); Expression profile; Glomeruli; Human; Kidney; Messenger RNA (mRNA)

Indexed keywords

AQUAPORIN 1; BONE MORPHOGENETIC PROTEIN 2; CALPAIN 3; CELL ADHESION MOLECULE; GLUCOSIDASE; HYALURONOGLUCOSIDASE; MESSENGER RNA; NEPHRIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CASE REPORT; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE COURSE; DNA MICROARRAY; FEMALE; GENE CONTROL; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; GLOMERULUS; HUMAN; HUMAN GENOME; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY BIOPSY; MALE; NUCLEOTIDE SEQUENCE; RNA HYBRIDIZATION; TISSUE REPAIR; UNINDEXED SEQUENCE; VALIDATION PROCESS;

EID: 1642422898     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2003.12.028     Document Type: Article

References (41)

1. John L, Kirubakaran MG, Shastry JC: Diabetic nephropathy: A clinical study of 498 patients. J Diabetes Complications 1:87-90, 1987
2. Mogensen CE, Chachati A, Christensen CK, et al: Microalbuminuria: An early marker of renal involvement in diabetes. Uremia Invest 9:85-95, 1985
3. Vleming LJ, Baelde JJ, Westendorp RG, Daha MR, van Es LA, Bruijn JA: The glomerular deposition of PAS positive material correlates with renal function in human kidney diseases. Clin Nephrol 47:158-167, 1997
4. Ziyadeh FN: The extracellular matrix in diabetic nephropathy. Am J Kidney Dis 22:736-744, 1993
5. Yamamoto T, Nakamura T, Noble NA, Ruoslahti E, Border WA: Expression of transforming growth factor β is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci U S A 90:1814-1818, 1993
6. Gambaro G, Baggio B: Growth factors and the kidney in diabetes mellitus. Crit Rev Clin Lab Sci 35:117-151, 1998
7. Wada J, Zhang H, Tsuchiyama Y, et al: Gene expression profile in streptozotocin-induced diabetic mice kidneys undergoing glomerulosclerosis. Kidney Int 59:1363-1373, 2001
8. Spiro RG: Studies on the renal glomerular basement membrane. Preparation and chemical composition. J Biol Chem 242:1915-1922, 1967
9. Eikmans M, Sijpkens YW, Baelde HJ, De Heer E, Paul LC, Bruijn JA: High transforming growth factor-beta and extracellular matrix mRNA response in renal allografts during early acute rejection is associated with absence of chronic rejection. Transplantation 73:573-579, 2002
10. Vandesompele J, De Preter K, Pattyn F, et al: Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3:RESEARCH0034, 2002
11. Specht K, Richter T, Muller U, Walch A, Werner M, Hofler H: Quantitative gene expression analysis in microdissected archival formalin-fixed and paraffin-embedded tumor tissue. Am J Pathol 158:419-429, 2001
12. Koop K, Eikmans M, Baelde HJ, et al: Expression of podocyte-associated molecules in acquired human kidney diseases. J Am Soc Nephrol 14:2063-2071, 2003
13. Doniger SW, Salomonis N, Dahlquist KD, Vranizan K, Lawlor SC, Conklin BR: MAPPFinder: Using Gene Ontology and GenMAPP to create a global gene-expression profile from microarray data. Genome Biol 4:R7, 2003
14. Azuma H, Nadeau K, Takada M, Mackenzie HS, Tilney NL: Cellular and molecular predictors of chronic renal dysfunction after initial ischemia/reperfusion injury of a single kidney. Transplantation 64:190-197, 1997
15. Eikmans M, Baelde HJ, De Heer E, Bruijn JA: Processing renal biopsies for diagnostic mRNA quantification: Improvement of RNA extraction and storage conditions. J Am Soc Nephrol 11:868-873, 2000
16. Stehouwer CD, Lambert J, Donker AJ, van Hinsbergh VW: Endothelial dysfunction and pathogenesis of diabetic angiopathy. Cardiovasc Res 34:55-68, 1997
17. Kelly DJ, Hepper C, Wu LL, Cox AJ, Gilbert RE: Vascular endothelial growth factor expression and glomerular endothelial cell loss in the remnant kidney model. Nephrol Dial Transplant 18:1286-1292, 2003
18. de Vriese AS, Tilton RG, Elger M, Stephan CC, Kriz W, Lameire NH: Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes. J Am Soc Nephrol 12:993-1000, 2001
19. Bailey E, Bottomley MJ, Westwell S, et al: Vascular endothelial growth factor mRNA expression in minimal change, membranous, and diabetic nephropathy demonstrated by non-isotopic in situ hybridisation. J Clin Pathol 52:735-738, 1999
20. Shulman K, Rosen S, Tognazzi K, Manseau EJ, Brown LF: Expression of vascular permeability factor (VPF/VEGF) is altered in many glomerular diseases. J Am Soc Nephrol 7:661-666, 1996
21. Cuevas P, Martinez-Coso V, Fu X, et al: Fibroblast growth factor protects the kidney against ischemia-reperfusion injury. Eur J Med Res 4:403-410, 1999
22. Striker GE, Eastman RD, Striker LJ: Diabetic nephropathy: Molecular analysis of extracellular matrix and clinical studies update. Nephrol Dial Transplant 11:S58-S61, 1996 (suppl 5)
23. Bohm BB, Aigner T, Blobel CP, Kalden JR, Burkhardt H: Highly enhanced expression of the disintegrin metalloproteinase MDC15 (metargidin) in rheumatoid synovial tissue. Arthritis Rheum 44:2046-2054, 2001
24. Sharma K, Jin Y, Guo J, Ziyadeh FN: Neutralization of TGF-beta by anti-TGF-beta antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice. Diabetes 45:522-530, 1996
25. Chen S, Hong SW, Iglesias-de la Cruz MC, Isono M, Casaretto A, Ziyadeh FN: The key role of the transforming growth factor-beta system in the pathogenesis of diabetic nephropathy. Ren Fail 23:471-481, 2001
26. Iwano M, Kubo A, Nishino T, et al: Quantification of glomerular TGF-beta 1 mRNA in patients with diabetes mellitus. Kidney Int 49:1120-1126, 1996
27. Yamamoto T, Noble NA, Cohen AH, et al: Expression of transforming growth factor-beta isoforms in human glomerular diseases. Kidney Int 49:461-469, 1996
28. Lam S, Verhagen NA, Strutz F, Van Der Pijl JW, Daha MR, Van Kooten C: Glucose-induced fibronectin and collagen type III expression in renal fibroblasts can occur independent of TGF-beta1. Kidney Int 63:878-888, 2003
29. Clayton A, Thomas J, Thomas GJ, Davies M, Steadman R: Cell surface heparan sulfate proteoglycans control the response of renal interstitial fibroblasts to fibroblast growth factor-2. Kidney Int 59:2084-2094, 2001
30. Price GJ, Berka JL, Werther GA, Bach LA: Cell-specific regulation of mRNAs for IGF-I and IGF-binding proteins-4 and -5 in streptozotocin-diabetic rat kidney. J Mol Endocrinol 18:5-14, 1997
31. McMahon R, Murphy M, Clarkson M, et al: IHG-2, a mesangial cell gene induced by high glucose, is human gremlin. Regulation by extracellular glucose concentration, cyclic mechanical strain, and transforming growth factor-beta1. J Biol Chem 275:9901-9904, 2000
32. Wolf G: Cell cycle regulation in diabetic nephropathy. Kidney Int Suppl 77:S59-S66, 2000
33. Wang S, Chen Q, Simon TC, et al: Bone morphogenic protein-7 (BMP-7), a novel therapy for diabetic nephropathy. Kidney Int 63:2037-2049, 2003
34. Nakada Y, Taniura H, Uetsuki T, Inazawa J, Yoshikawa K: The human chromosomal gene for necdin, a neuronal growth suppressor, in the Prader-Willi syndrome deletion region. Gene 213:65-72, 1998
35. Diamandis EP: Clinical applications of tumor suppressor genes and oncogenes in cancer. Clin Chim Acta 257:157-180, 1997
36. Ichimura T, Maier JA, Maciag T, Zhang G, Stevens JL: FGF-1 in normal and regenerating kidney: Expression in mononuclear, interstitial, and regenerating epithelial cells. Am J Physiol 269:F653-F662, 1995
37. Kestila M, Lenkkeri U, Mannikko M, et al: Positionally cloned gene for a novel glomerular protein-Nephrin - Is mutated in congenital nephrotic syndrome. Mol Cell 1:575-582, 1998
38. Langham RG, Kelly DJ, Cox AJ, et al: Proteinuria and the expression of the podocyte slit diaphragm protein, nephrin, in diabetic nephropathy: Effects of angiotensin converting enzyme inhibition. Diabetologia 45:1572-1576, 2002
39. Doublier S, Salvidio G, Lupia E, et al: Nephrin expression is reduced in human diabetic nephropathy: Evidence for a distinct role for glycated albumin and angiotensin II. Diabetes 52:1023-1030, 2003
40. Forbes JM, Bonnet F, Russo LM, et al: Modulation of nephrin in the diabetic kidney: Association with systemic hypertension and increasing albuminuria. J Hypertens 20:985-992, 2002
41. Palmer RE, Kotsianti A, Cadman B, Boyd T, Gerald W, Haber DA: WT1 regulates the expression of the major glomerular podocyte membrane protein podocalyxin. Curr Biol 11:1805-1809, 2001